AN EVALUATION OF PROMAZINE HYDROCHLORIDE IN PSYCHIATRIC PRACTICE
Abstract
1. Fifty psychiatric patients treated with promazine hydrochloride, a new phenothiazine derivative, are reviewed.
2. The drug was effective in one-third of the patients treated, but only in those who demonstrated marked anxiety.
3. Dosages and methods of administration are considered.
4. Adverse side-effects are mild and relatively uncommon as compared with those produced by chlorpromazine.
5. Promazine appears to be as effective as chlorpromazine as a tranquillizer in psychiatric practice and deserves further study.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
